Characterization of patients with pre-diabetes in first-level health care service institutions Cali, Colombia
Main Article Content
Objectives: To detect patients with pre-diabetes who are members of a private health care provider (EPS for its name in Spanish) in Cali and to describe the clinical and epidemiological characteristics related to the risk of developing DM 2.
Materials and methods: This is a cross-sectional descriptive study in patients with altered glucemias (Impaired fasting glucose: 100-125 mg/dl and impaired glucose tolerance: 140-199 mg/dl). Clinical histories were reviewed and surveys on risk factors, habits and perception of knowledge were conducted. We determined: fasting glucose, vital signs, and anthropometric measures.
Results: 111 patients were included (64% women) whose most common occupation was home duties (39.6%). The descriptive analysis reported high risk; the results were: noticeable presence of associate pathological antecedents as follows: Diabetes in the family (64%), obesity (54.1%), dyslipidemia (72.1%), and hypertension (66.7%) in a population with a mean age at 51 years and 10.8% were under 40 years of age. This great proportion of overweight or obesity (86.5%), according to BMI, influenced the determination of the high cardio-metabolic risk (81%, agreeing with the WHO). When evaluating diet with consumption frequency, we still found the intake of simple carbohydrates and animal fats; when reviewing physical activity, 53.2% of the patients reported activity in the last 7 days according to the International Physical Activity Questionnaire (IPAQ).
Conclusions: 66% of pre-diabetics did not have diagnosis of some disorder of the metabolism of carbohydrates. More than 70% of the patients have high risk of DM 2 with pathological antecedents, inadequate health habits, and low perception of disease complications.
- Estado prediabético
- Intolerancia a la glucosa
- Diabetes tipo II
- Prevención primaria
- índrome X metabólico
Codario R. Pathophysiology of type 2 diabetes. In: Type 2diabetes, pre-diabetes, and the metabolic syndrome: Theprimary guide to diagnosis and management. Totowa: Huma-na Press Inc; 2005. p. 1-12.2.Rao S, Disraeli P, McGregor T. Impaired glucose toleranceand impaired fasting glucose. Am Fam Physician. 2004; 69:1961-8.3.Leahy J. α-Cell dysfunction in type 2 diabetes mellitus. In:KahnC. R, Weir G, King G, Jacobson A, Smith R, Moses A(eds). Joslin’s diabetes mellitus.14th ed. Boston: LippincottWilliams & Wilkins; 2006. p. 449-61.4.Ceriello A. Post-Prandial endothelial dysfunction, oxidativestress, and inflammation in type 2 diabetes. In : Packer L, SiesH, (eds). Oxidative stress and inflammatory mechanisms inobesity, diabetes, and the metabolic syndrome. Boca Raton:CRC Press; 2008. p. 123-37.5.World Health Organization. Definition, diagnosis andclassification of diabetes mellitus and its complications:Report of a WHO Consultation. Geneva: WHO/NCD/NCS/99.2; 1999.6.Nathan D, Delahanty L. Beating diabetes. Chicago: McGraw-Hill; 2005. p.1-19.7.Sicree R, Shaw J, Zimmet P. The Global Burden: Diabetes andimpaired glucose tolerance. In: Diabetes Atlas. 4th ed.
Colombia Médica Vol. 42 Nº 1, 2011 (Enero-Marzo)Brusselas: International Diabetes Federation (IDF); 20098.Centro para el Desarrollo y Evaluación de Políticas y Tecno-logía en Salud Pública (CEDETES), Universidad del Valle,Secretaria de Salud Pública Municipal de Cali. Situación desalud de Cali. Una mirada desde la salud pública. Cali:CEDETES, UniValle, SSPMC; 2007.9.Asociación Latinoamericana de Diabetes. Guías ALAD dediagnóstico, control y tratamiento de la diabetes mellitus tipo2. Bogotá, DC:Asociación Latinoamericana de Diabetes;2007.10. Diabetes prevention program research group. Reduction in theincidence of type 2 diabetes with lifestyle intervention ormetformin. N Engl J Med. 2002; 346: 393-403.11. Ministerio de la Protección Social. Guía de atención de ladiabetes mellitus Tipo 2. Bogotá, DC: Ministerio de la Protec-ción Social; 2007.12.Bazán N, Díaz G, Kunik H, O’Connor C, Gavini K. IPASTANGO: La aplicación del Cuestionario Internacional deActividad Física (IPAQ) en la Ciudad de Buenos Aires.Buenos Aires: Instituto Superior de Deportes, AsociaciónMetropolitana de Medicina del Deporte; 2003.13. International Diabetes Federation. The IDF consensusworldwide definition of the metabolic Syndrome. Brussels:Promoting Diabetes Care, Prevention and a Cure Worldwide;2006.14. Blaha M, Bansal S, Rouf R, Golden S, Blumenthal R, DefilippisA. Practical «ABCDE» approach to the metabolic syndrome.Mayo Clin Proc. 2008; 83: 932-43.15. Benjamin S, Valdez R, Geiss L, Rolka D, Venkat K. Estimatednumber of adults with pre-diabetes in the US in 2000.Diabetes Care. 2003; 26: 645-9.16. Jonk A, Houben A, De Jongh R, Serné E, Schaper N, StehouwerC. Micro-vascular dysfunction in obesity: A potentialmechanism in the pathogenesis of obesity associated insulinresistance and hypertension. Physiol Rev. 2007; 22: 252-60.17. Dabelea D, Bell R, D’Agostino R, Imperatore G, Johansen J,Linder B, et al. Incidence of diabetes in youth in the UnitedStates. JAMA. 2007; 297: 2716-24.18. American Diabetes Association. Standards of medical care indiabetes, 2010. Diabetes Care. 2010; 33 (Suppl 1): S11-61.19. Alberti KG, Zimmet P, Shaw J. International DiabetesFederation: a consensus on type 2 diabetes prevention. DiabetMed. 2007; 24: 451-63.20. Bovet P, Faeh D, Paccaud F, William J, Yerly P. Diabetes andpre-diabetes are associated with cardiovascular risk factorsand carotid/femoral intima-media thickness independently ofmarkers of insulin resistance and adiposity. Cardiovas diabetol.2007; 6: 32.21. Serra M, Aranceta LI, Mataix J. Nutrición y salud pública. 2aed. Barcelona: MASSON; 2006.22. Seidel M, Powell R, Piatt G. Translating the diabetes preventionprogram in an urban underserved community: long termsustainability of positive clinical outcomes. Diabetes. 2007;56 (Supp): A42
Downloads
- Cristhian Hernandez-Gomez, Marta Vallejo, Gabriel Motoa, Victor M Blanco, Adriana Correa, Elsa de la Cadena, Maria Virginia Villegas, Introduction of software tools for epidemiological surveillance in infection control in Colombia , Colombia Medica: Vol. 46 No. 2 (2015)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use